C3a, depending on the circumstances, is a pro- or anti-inflammatory mediator and is associated with an increased risk of diabetic retinopathy, nephropathy, neuropathy (106), and cardiomyopathy (107). This evidence concerns the gene C3 and diabetic retinopathy.